Estrogens Effect on Pain in Postmenopausal Women Suffering of Fibromyalgia

NCT01087593 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2010-03-16

No results posted yet for this study

Summary

In order to evaluate the potential effects of estrogen treatment in postmenopausal women with fibromyalgia, the investigators used quantitative sensory tests before and after eight weeks of estrogen treatment as compared with placebo treatment.

Conditions

  • Fibromyalgia

Interventions

DRUG

17β-estradiol

Transdermal administration(50 ug daily)for a period of ten weeks with additional treatment of medroxyprogesterone (10mg daily) for the last two weeks

Sponsors & Collaborators

  • Ostergotland County Council, Sweden

    lead OTHER

Principal Investigators

  • Mats Hammar, MD, prof · University Hospital, Linkoeping

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087593 on ClinicalTrials.gov